Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 21 , ISSUE 10 ( 2017 ) > List of Articles

REVIEW ARTICLE

Capillary leak syndrome following snakebite envenomation

V Udayabhaskaran, E. T. Thomas, Bhagya Shaji

Keywords : envenomation, Russell\'s viper, Snakebite,Capillary leak syndrome

Citation Information : Udayabhaskaran V, Thomas ET, Shaji B. Capillary leak syndrome following snakebite envenomation. Indian J Crit Care Med 2017; 21 (10):698-702.

DOI: 10.4103/ijccm.IJCCM_41_17

License: CC BY-ND 3.0

Published Online: 00-10-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Capillary leak syndrome is a unique complication that follows Russell\'s viper envenomation. This syndrome has a very high fatality rate and is characterized by parotid swelling, chemosis, periorbital edema, hypotension, albuminuria, hypoalbuminemia, and hemoconcentration. This syndrome is frequently recognized from the southern parts of India, especially from the state of Kerala. It has been postulated that a vascular apoptosis inducing component of Russell\'s viper venom that is not neutralized by the commercially available anti-snake venom (ASV) is responsible for this complication as it occurs even after adequate doses of ASV administration in most cases. Acute kidney injury often requiring dialysis is invariably present in all patients because of reduced renal perfusion and ischemic acute tubular necrosis as a result of hypotension. Management mainly involves aggressive fluid resuscitation to maintain adequate tissue perfusion. There are no other proven effective treatment modalities, except a few reports of successful treatment with plasmapheresis. Methylprednisolone pulse therapy, terbutaline, aminophylline, and intravenous immunoglobulin are other treatment modalities tried.


PDF Share
  1. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, et al. The global burden of snakebite: A literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med 2008;5:e218.
  2. Krishnadas T, Sasidharan PK. Snake bites in North Kerala, demographic profile and measures for prevention. J Evol Med Dent Sci 2014;3:990-8.
  3. Masuda S, Hayashi H, Araki S. Two vascular apoptosis-inducing proteins from snake venom are members of the metalloprotease/disintegrin family. Eur J Biochem 1998;253:36-41.
  4. Suhr SM, Kim DS. Identification of the snake venom substance that induces apoptosis. Biochem Biophys Res Commun 1996;224:134-9.
  5. Torii S, Yamane K, Mashima T, Haga N, Yamamoto K, Fox JW, et al. Molecular cloning and functional analysis of apoxin I, a snake venom-derived apoptosis-inducing factor with L-amino acid oxidase activity. Biochemistry 2000;39:3197-205.
  6. Zamuner SR, Zuliani JP, Fernandes CM, Gutiérrez JM, de Fátima Pereira Teixeira C. Inflammation induced by Bothrops asper venom: Release of proinflammatory cytokines and eicosanoids, and role of adhesion molecules in leukocyte infiltration. Toxicon 2005;46:806-13.
  7. Petricevich VL, Teixeira CF, Tambourgi DV, Gutiérrez JM. Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms. Toxicon 2000;38:1253-66.
  8. Moreira V, Zamuner SR, Wallace JL, Teixeira Cde F. Bothrops jararaca and Crotalus durissus terrificus venoms elicit distinct responses regarding to production of prostaglandins E2 and D2, and expression of cyclooxygenases. Toxicon 2007;49:615-24.
  9. Zuliani JP, Fernandes CM, Zamuner SR, Gutiérrez JM, Teixeira CF. Inflammatory events induced by Lys-49 and Asp-49 phospholipases A2 isolated from Bothrops asper snake venom: Role of catalytic activity. Toxicon 2005;45:335-46.
  10. Kini RM. Excitement ahead: Structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon 2003;42:827-40.
  11. Perumal Samy R, Gopalakrishnakone P, Bow H, Puspharaj PN, Chow VT. Identification and characterization of a phospholipase A2 from the venom of the Saw-scaled viper: Novel bactericidal and membrane damaging activities. Biochimie 2010;92:1854-66.
  12. Thomas ET, Bhagya S, Udayabhaskaran V, Kumar KG, Thulaseedharan NK. Is the concept of “big 4” still relevant in India? Comparison of envenomation by hump-nosed pit viper with russell's viper. Eur J Pharm Med Res 2016;3:306-10.
  13. Whitaker R, Whitaker S. Venom, antivenom production and the medically important snakes of India. Curr Sci 2012;103:635-43.
  14. Sharma M, Gogoi N, Dhananjaya BL, Menon JC, Doley R. Geographical variation of Indian Russell's viper venom and neutralization of its coagulopathy by polyvalent antivenom. Toxin Rev 2014;3:1-15.
  15. Warrell DA. Guidelines for the management of snake-bites [Internet]. World Health Organization Regional Office for South-East Asia; 2010. Available from: http://apps.searo.who.int/PDS_DOCS/B4508.pdf. [Last cited on 2017 Oct 01].
  16. Thomas RG, Kumar J. Clinical features, prognostic factors & outcome of capillary leak syndrome in snake bite envenomation. Int J Adv Res 2016;4:2707-10.
  17. Kulkarni C, George TA, Av A, Ravindran R. Acute angle closure glaucoma with Capilllary leak syndrome following snake bite. J Clin Diagn Res 2014;8:VC01-3.
  18. Srinivasan R, Kaliaperumal S, Dutta TK. Bilateral angle closure glaucoma following snake bite. J Assoc Physicians India 2005;53:46-8.
  19. Mohd H, Veena V. Acute angle closure glaucoma: Rare complication of viper bite. KMJ 2008;2:27-8.
  20. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
  21. ProCESS Investigators, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. Arandomized trial of protocol-based care for early septic shock. N Engl J Med 2014;370:1683-93.
  22. ARISE Investigators, ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, Bellomo R, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014;371:1496-506.
  23. Atkinson JP, Waldmann TA, Stein SF, Gelfand JA, Macdonald WJ, Heck LW, et al. Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature. Medicine (Baltimore) 1977;56:225-39.
  24. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Šneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367:124-34.
  25. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
  26. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
  27. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
  28. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779-89.
  29. Abstracts of the 27th international symposium on intensive care and emergency medicine, Brussels, Belgium, 27-30 March 2007. Crit Care 2007;11 Suppl 2:S1-201.
  30. Walsh JT, Hildick-Smith DJ, Newell SA, Lowe MD, Satchithananda DK, Shapiro LM, et al. Comparison of central venous and inferior vena caval pressures. Am J Cardiol 2000;85:518-20, A11.
  31. Brennan JM, Ronan A, Goonewardena S, Blair JE, Hammes M, Shah D, et al. Handcarried ultrasound measurement of the inferior vena cava for assessment of intravascular volume status in the outpatient hemodialysis clinic. Clin J Am Soc Nephrol 2006;1:749-53.
  32. Mandelbaum A, Ritz E. Vena cava diameter measurement for estimation of dry weight in haemodialysis patients. Nephrol Dial Transplant 1996;11 Suppl 2:24-7.
  33. Grace M, Jacob KJ, Jayakumar, Arun P. Secondary capillary leak syndrome – Plasmapheresis: Is it the answer? IAIM 2015;2:187-9.
  34. Zengin S, Yilmaz M, Al B, Yildirim C, Yarbil P, Kilic H, et al. Plasma exchange as a complementary approach to snake bite treatment: An academic emergency department's experiences. Transfus Apher Sci 2013;49:494-8.
  35. Amoura Z, Papo T, Ninet J, Hatron PY, Guillaumie J, Piette AM, et al. Systemic capillary leak syndrome: Report on 13 patients with special focus on course and treatment. Am J Med 1997;103:514-9.
  36. Tahirkheli NK, Greipp PR. Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. A case series. Ann Intern Med 1999;130:905-9.
  37. Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet 1984;2:765-8.
  38. Suchithra N, Pappachan JM, Sujathan P. Snakebite envenoming in Kerala, South India: Clinical profile and factors involved in adverse outcomes. Emerg Med J 2008;25:200-4.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.